Doug Coyle

16.0k total citations · 2 hit papers
298 papers, 10.7k citations indexed

About

Doug Coyle is a scholar working on Economics and Econometrics, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Doug Coyle has authored 298 papers receiving a total of 10.7k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Economics and Econometrics, 37 papers in Oncology and 35 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Doug Coyle's work include Health Systems, Economic Evaluations, Quality of Life (91 papers), Pharmaceutical Economics and Policy (28 papers) and Economic and Financial Impacts of Cancer (21 papers). Doug Coyle is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (91 papers), Pharmaceutical Economics and Policy (28 papers) and Economic and Financial Impacts of Cancer (21 papers). Doug Coyle collaborates with scholars based in Canada, United Kingdom and United States. Doug Coyle's co-authors include George A. Wells, Peter Tugwell, Chris Cameron, Tammy Clifford, Ann Cranney, Vivian Welch, Joan Peterson, Eva Grunfeld, Beverley Shea and Michel Boucher and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Doug Coyle

289 papers receiving 10.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial.

2007 937 citations George A. Wells, Doug Coyle et al. profile →
Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis

2015 441 citations Chris Cameron, Doug Coyle et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Doug Coyle Canada	51	1.9k	1.6k	1.5k	1.4k	1.2k	298	10.7k
Elizabeth A. Chrischilles United States	52	1.9k 1.0×	1.6k 1.0×	1.2k 0.8×	1.9k 1.4×	595 0.5×	238	10.4k
Hubert G. M. Leufkens Netherlands	58	2.2k 1.1×	2.4k 1.5×	1.3k 0.8×	1.7k 1.2×	1.2k 1.0×	415	14.4k
Peter T. Donnan United Kingdom	60	1.4k 0.7×	914 0.6×	1.4k 0.9×	2.5k 1.8×	1.4k 1.2×	260	13.1k
Yong‐Fang Kuo United States	61	3.2k 1.7×	1.1k 0.7×	1.1k 0.7×	2.2k 1.6×	932 0.8×	497	14.0k
Til Stürmer‎ United States	60	1.9k 1.0×	2.6k 1.6×	1.4k 0.9×	2.3k 1.7×	601 0.5×	334	14.5k
Julia Hippisley–Cox United Kingdom	68	1.6k 0.8×	1.6k 1.0×	3.5k 2.3×	2.9k 2.1×	1.0k 0.9×	241	16.5k
Diana B. Petitti United States	58	1.2k 0.6×	859 0.5×	1.5k 1.0×	1.6k 1.1×	1.3k 1.1×	194	13.8k
Kathleen Bennett Ireland	57	961 0.5×	2.2k 1.3×	2.0k 1.3×	1.3k 0.9×	615 0.5×	481	12.1k
Carol Coupland United Kingdom	72	1.8k 0.9×	1.4k 0.9×	3.1k 2.0×	3.4k 2.5×	1.0k 0.9×	297	17.9k
Yoon K. Loke United Kingdom	58	591 0.3×	1.2k 0.7×	2.2k 1.4×	1.9k 1.4×	1.7k 1.4×	248	12.9k

Countries citing papers authored by Doug Coyle

Since Specialization

Citations

This map shows the geographic impact of Doug Coyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doug Coyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doug Coyle more than expected).

Fields of papers citing papers by Doug Coyle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doug Coyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doug Coyle. The network helps show where Doug Coyle may publish in the future.

Co-authorship network of co-authors of Doug Coyle

This figure shows the co-authorship network connecting the top 25 collaborators of Doug Coyle. A scholar is included among the top collaborators of Doug Coyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doug Coyle. Doug Coyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Coyle, Doug. (2025). Implementing a smoke-free generation policy for Canada: estimates of the long-term impacts. Health Promotion and Chronic Disease Prevention in Canada. 45(1). 39–53. 1 indexed citations

Coyle, Doug, et al.. (2024). The Development of a Model Validation Tool to Assist in the Conduct of Economic Evaluations. Canadian Journal of Health Technologies. 4(3). 2 indexed citations

Fell, Deshayne B., Steven Hawken, Beth K. Potter, et al.. (2023). Relationship Between Gestational Weight Gain and Health Service Utilization in Early Childhood: A Retrospective Cohort Study. Maternal and Child Health Journal. 28(3). 426–430.

Khan, Faizan, Doug Coyle, Kednapa Thavorn, et al.. (2023). Indefinite Anticoagulant Therapy for First Unprovoked Venous Thromboembolism. Annals of Internal Medicine. 176(7). 949–960. 6 indexed citations

Gaskin, Janet, et al.. (2021). Regional cost effectiveness analyses for increasing radon protection strategies in housing in Canada. Journal of Environmental Radioactivity. 240. 106752–106752. 1 indexed citations

Thavorn, Kednapa, Ian D. Graham, Harold Atkins, et al.. (2021). Stakeholder engagement in economic evaluation: Protocol for using the nominal group technique to elicit patient, healthcare provider, and health system stakeholder input in the development of an early economic evaluation model of chimeric antigen receptor T-cell therapy. BMJ Open. 11(8). e046707–e046707. 5 indexed citations

Gaskin, Janet, Jeff Whyte, & Doug Coyle. (2020). An assessment of uncertainty using two different modelling techniques to estimate the cost effectiveness of mitigating radon in existing housing in Canada. The Science of The Total Environment. 724. 138092–138092. 5 indexed citations

Werier, Joel, et al.. (2019). A technique for approximating transition rates from published survival analyses. Cost Effectiveness and Resource Allocation. 17(1). 12–12. 10 indexed citations

Elliott, Jesse, Deirdre DeJean, Tammy Clifford, et al.. (2019). Cannabis-based products for pediatric epilepsy: An updated systematic review. Seizure. 75. 18–22. 28 indexed citations

10.

Katwyk, Sasha van, Kednapa Thavorn, Doug Coyle, et al.. (2018). The return of investment of hospital-based surgical quality improvement programs in reducing surgical site infection at a Canadian tertiary-care hospital. Infection Control and Hospital Epidemiology. 40(2). 125–132. 8 indexed citations

11.

Coyle, Doug, Yoo‐Joung Ko, Kathryn Coyle, et al.. (2017). Cost-Effectiveness Analysis of Systemic Therapies in Advanced Pancreatic Cancer in the Canadian Health Care System. Value in Health. 20(4). 586–592. 17 indexed citations

12.

Pokhrel, Subhash, Lesley Owen, Adam Lester‐George, et al.. (2014). The NICE tobacco return on investment tool. Brunel University Research Archive (BURA) (Brunel University London). 2 indexed citations

13.

Cameron, Chris, Doug Coyle, Trevor Richter, et al.. (2014). Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation. BMJ Open. 4(6). e004301–e004301. 93 indexed citations

14.

Castellucci, Lana A., Chris Cameron, Grégoire Le Gal, et al.. (2013). Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis. BMJ. 347(aug30 1). f5133–f5133. 144 indexed citations

15.

Potter, Beth K., Pranesh Chakraborty, Jonathan B. Kronick, et al.. (2012). Achieving the “triple aim” for inborn errors of metabolism: a review of challenges to outcomes research and presentation of a new practice-based evidence framework. Genetics in Medicine. 15(6). 415–422. 21 indexed citations

16.

Mittmann, Nicole, William K. Evans, Angela Rocchi, et al.. (2012). Guidelines for Health Technologies: Specific Guidance for Oncology Products in Canada. Value in Health. 15(3). 580–585. 13 indexed citations

17.

Fox‐Rushby, Julia, Gary L. Griffith, Joy Ross, et al.. (2010). The clinical and cost-effectiveness of different treatment pathways for neuropathic pain (NP). ePrints Soton (University of Southampton). 1 indexed citations

18.

Potter, Beth K., Holly Etchegary, Heather Howley, et al.. (2008). Exploring informed choice in the context of prenatal testing: findings from a qualitative study. Health Expectations. 11(4). 355–365. 47 indexed citations

19.

Etchegary, Holly, Beth K. Potter, Heather Howley, et al.. (2008). The Influence of Experiential Knowledge on Prenatal Screening and Testing Decisions. Genetic Testing. 12(1). 115–124. 63 indexed citations

20.

Imamura, Mari, Shimin Zhu, Cathryn Glazener, et al.. (2008). A systematic review of the clinical effectiveness and cost-effectiveness and economic modelling of minimal incision total hip replacement approaches in the management of arthritic disease of the hip. Health Technology Assessment. 12(26). iii–iv, ix. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact